Abstract
While new prescription rates for most medications to treat behavioral health conditions were steady during the COVID‐19 pandemic, prescriptions for attention deficit hyperactivity disorder (ADHD) medications rose sharply, a study published last week in JAMA Psychiatry found. The largest increases in ADHD medication prescriptions were among women and people aged 20 to 39, according to an APA Psychiatric News Alert.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
